Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-02-27 @ 7:05 PM
Study NCT ID:
NCT00652158
Status:
TERMINATED
Last Update Posted:
2013-09-23
First Post:
2008-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C10002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None